Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response: A comparative study with FK-506

Masutaka Furue, Atsushi Osada, Chung Hsing Chang, Kunihiko Tamaki

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Azelastine hydrochloride (AZE) is an anti-allergic drag that inhibits the release of various chemical mediators from mast cells. We compared the immunosuppressive effects of AZE and FK-506 in vivo and in vitro. Topical application of AZE strongly inhibited the efferent phase of contact hypersensitivity, as did application of FK-506. In in vitro experiments, we found that 1) the suppression by AZE on interleukin (IL)-2 production from splenic T cells was partial and considerably large amounts of IL-2 were still produced, even in the presence of 10 -5 M of AZE, which was in sharp contrast to the observed marked inhibition of [ 3 H]-TdR incorporation; 2) AZE significantly inhibited the phorbol myristate acetate-induced IL-2 responsiveness; 3) AZE did not inhibit the IL-2 receptor α expression of activated T cells; and 4) the significant inhibitory action was still observed even when AZE was added at 48 h after the initiation of culture. In regard to FK-506, we found that 1) FK-506 completely blocked the production of IL-2; 2) exogeneous IL-2 consistently restored the FK-506 - induced inhibition; 3) FK-506 affected the phorbol myristate acetate-induced IL-2 responsiveness very little, if any; and 4) the significant suppression was observed only when FK-506 was added within 24 h after the initiation of culture. Thus, AZE exerts its in vitro immunosuppressive activity preferentially by interfering with the IL-2 responsiveness, with partial inhibition of IL-2 production. Conversely, FK-506 acts as a strong inhibitor of IL-2 production without a prominent effect on IL-2 responsiveness. The immunosuppressive activity of AZE shown in vitro may also be operative in vivo and may be applicable for topical use.

Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalJournal of Investigative Dermatology
Volume103
Issue number1
DOIs
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

azelastine
T-cells
Contact Dermatitis
Tacrolimus
Immunosuppressive Agents
Interleukin-2
T-Lymphocytes
Tetradecanoylphorbol Acetate
Anti-Allergic Agents
Interleukin-2 Receptors

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response : A comparative study with FK-506. / Furue, Masutaka; Osada, Atsushi; Chang, Chung Hsing; Tamaki, Kunihiko.

In: Journal of Investigative Dermatology, Vol. 103, No. 1, 01.01.1994, p. 49-53.

Research output: Contribution to journalArticle

@article{aac1cfe53b094c07bb776168120d2a99,
title = "Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response: A comparative study with FK-506",
abstract = "Azelastine hydrochloride (AZE) is an anti-allergic drag that inhibits the release of various chemical mediators from mast cells. We compared the immunosuppressive effects of AZE and FK-506 in vivo and in vitro. Topical application of AZE strongly inhibited the efferent phase of contact hypersensitivity, as did application of FK-506. In in vitro experiments, we found that 1) the suppression by AZE on interleukin (IL)-2 production from splenic T cells was partial and considerably large amounts of IL-2 were still produced, even in the presence of 10 -5 M of AZE, which was in sharp contrast to the observed marked inhibition of [ 3 H]-TdR incorporation; 2) AZE significantly inhibited the phorbol myristate acetate-induced IL-2 responsiveness; 3) AZE did not inhibit the IL-2 receptor α expression of activated T cells; and 4) the significant inhibitory action was still observed even when AZE was added at 48 h after the initiation of culture. In regard to FK-506, we found that 1) FK-506 completely blocked the production of IL-2; 2) exogeneous IL-2 consistently restored the FK-506 - induced inhibition; 3) FK-506 affected the phorbol myristate acetate-induced IL-2 responsiveness very little, if any; and 4) the significant suppression was observed only when FK-506 was added within 24 h after the initiation of culture. Thus, AZE exerts its in vitro immunosuppressive activity preferentially by interfering with the IL-2 responsiveness, with partial inhibition of IL-2 production. Conversely, FK-506 acts as a strong inhibitor of IL-2 production without a prominent effect on IL-2 responsiveness. The immunosuppressive activity of AZE shown in vitro may also be operative in vivo and may be applicable for topical use.",
author = "Masutaka Furue and Atsushi Osada and Chang, {Chung Hsing} and Kunihiko Tamaki",
year = "1994",
month = "1",
day = "1",
doi = "10.1111/1523-1747.ep12389548",
language = "English",
volume = "103",
pages = "49--53",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response

T2 - A comparative study with FK-506

AU - Furue, Masutaka

AU - Osada, Atsushi

AU - Chang, Chung Hsing

AU - Tamaki, Kunihiko

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Azelastine hydrochloride (AZE) is an anti-allergic drag that inhibits the release of various chemical mediators from mast cells. We compared the immunosuppressive effects of AZE and FK-506 in vivo and in vitro. Topical application of AZE strongly inhibited the efferent phase of contact hypersensitivity, as did application of FK-506. In in vitro experiments, we found that 1) the suppression by AZE on interleukin (IL)-2 production from splenic T cells was partial and considerably large amounts of IL-2 were still produced, even in the presence of 10 -5 M of AZE, which was in sharp contrast to the observed marked inhibition of [ 3 H]-TdR incorporation; 2) AZE significantly inhibited the phorbol myristate acetate-induced IL-2 responsiveness; 3) AZE did not inhibit the IL-2 receptor α expression of activated T cells; and 4) the significant inhibitory action was still observed even when AZE was added at 48 h after the initiation of culture. In regard to FK-506, we found that 1) FK-506 completely blocked the production of IL-2; 2) exogeneous IL-2 consistently restored the FK-506 - induced inhibition; 3) FK-506 affected the phorbol myristate acetate-induced IL-2 responsiveness very little, if any; and 4) the significant suppression was observed only when FK-506 was added within 24 h after the initiation of culture. Thus, AZE exerts its in vitro immunosuppressive activity preferentially by interfering with the IL-2 responsiveness, with partial inhibition of IL-2 production. Conversely, FK-506 acts as a strong inhibitor of IL-2 production without a prominent effect on IL-2 responsiveness. The immunosuppressive activity of AZE shown in vitro may also be operative in vivo and may be applicable for topical use.

AB - Azelastine hydrochloride (AZE) is an anti-allergic drag that inhibits the release of various chemical mediators from mast cells. We compared the immunosuppressive effects of AZE and FK-506 in vivo and in vitro. Topical application of AZE strongly inhibited the efferent phase of contact hypersensitivity, as did application of FK-506. In in vitro experiments, we found that 1) the suppression by AZE on interleukin (IL)-2 production from splenic T cells was partial and considerably large amounts of IL-2 were still produced, even in the presence of 10 -5 M of AZE, which was in sharp contrast to the observed marked inhibition of [ 3 H]-TdR incorporation; 2) AZE significantly inhibited the phorbol myristate acetate-induced IL-2 responsiveness; 3) AZE did not inhibit the IL-2 receptor α expression of activated T cells; and 4) the significant inhibitory action was still observed even when AZE was added at 48 h after the initiation of culture. In regard to FK-506, we found that 1) FK-506 completely blocked the production of IL-2; 2) exogeneous IL-2 consistently restored the FK-506 - induced inhibition; 3) FK-506 affected the phorbol myristate acetate-induced IL-2 responsiveness very little, if any; and 4) the significant suppression was observed only when FK-506 was added within 24 h after the initiation of culture. Thus, AZE exerts its in vitro immunosuppressive activity preferentially by interfering with the IL-2 responsiveness, with partial inhibition of IL-2 production. Conversely, FK-506 acts as a strong inhibitor of IL-2 production without a prominent effect on IL-2 responsiveness. The immunosuppressive activity of AZE shown in vitro may also be operative in vivo and may be applicable for topical use.

UR - http://www.scopus.com/inward/record.url?scp=0028235956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028235956&partnerID=8YFLogxK

U2 - 10.1111/1523-1747.ep12389548

DO - 10.1111/1523-1747.ep12389548

M3 - Article

C2 - 7517981

AN - SCOPUS:0028235956

VL - 103

SP - 49

EP - 53

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 1

ER -